Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neuro-Oncology Advances|August 30, 2024
Phase 1 study of concomitant tumor treating fields and temozolomide chemoradiation for newly diagnosed glioblastomaSamuel A Goldlust, Samuel Singer, Lori A Cappello, et al.Frontiers in Surgery|January 22, 2025
Preoperative anemia is associated with prolonged hospital stay and increased facility discharges after glioblastoma resectionAhmad K Almekkawi, Ammar Adenwalla, James P Caruso, et al.Science Advances|June 22, 2022
Temozolomide-induced guanine mutations create exploitable vulnerabilities of guanine-rich DNA and RNA regions in drug-resistant gliomasDeanna M Tiek, Beril Erdogdu, Roham Razaghi, et al.The Lancet. Oncology|August 29, 2017
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trialMichael Weller, Nicholas Butowski, David D Tran, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2025
Dual Immune Check Point Blockade in <i>MGMT</i>-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical TrialAndrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, et al.American Journal of Hematology|March 25, 2023
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centersKevin A David, Suchitra Sundaram, Seo-Hyun Kim, et al.Leukemia & Lymphoma|March 24, 2023
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohortPrashasti Agrawal, Kevin A David, Zhengming Chen, et al.Journal of Translational Medicine|July 1, 2018
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.Journal of Translational Medicine|May 31, 2018
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastomaLinda M Liau, Keyoumars Ashkan, David D Tran, et al.JAMA Oncology|November 17, 2022
Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort TrialLinda M Liau, Keyoumars Ashkan, Steven Brem, et al.Pageof 2